Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Martinez

Showing results (461-470 of 600) with videos related to

Pageof 60
Sort By:
JCI Insight|February 19, 2026
Pediatric long COVID is characterized by myeloid CCR6 suppression and immune dysregulationJon Izquierdo-Pujol, Núria Pedreño-Lopez, Tetyana Pidkova, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 ProtocolJuliana Salazar, María J Arranz, Javier Martin-Broto, et al.
Vaccines|December 11, 2019
Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMixWesley de Jong, Lorna Leal, Jozefien Buyze, et al.
The Journal of Infectious Diseases|May 8, 2021
Early Initiation of Antiretroviral Therapy Following In Utero HIV Infection Is Associated With Low Viral Reservoirs but Other Factors Determine Viral ReboundJane R Millar, Nomonde Bengu, Vinicius A Vieira, et al.
Plos One|August 2, 2017
UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-conceptJavier Martinez-Useros, Tihomir Georgiev-Hristov, María Jesús Fernández-Aceñero, et al.
Current Medicinal Chemistry|April 11, 2025
Assessment of the Toxicity of Free and PLGA-Encapsulated Phospholipase A2 CB: An In Vitro ApproachVanessa Barbosa Pinheiro Gonçalves, Gabriel Acácio de Moura, João Pedro Viana Rodrigues, et al.
The American Journal of Tropical Medicine and Hygiene|July 8, 2015
Safety and Immunogenicity of a Dengue Virus Serotype-1 Purified-Inactivated Vaccine: Results of a Phase 1 Clinical TrialLuis Javier Martinez, Leyi Lin, Jason M Blaylock, et al.
BMC Cancer|December 18, 2014
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancerJavier Martinez-Useros, Maria Rodriguez-Remirez, Aurea Borrero-Palacios, et al.
Annals of Surgical Oncology|January 23, 2015
Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS)Jordi Rubió-Casadevall, Javier Martinez-Trufero, Xabier Garcia-Albeniz, et al.
The Journal of Clinical Investigation|November 29, 2024
Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoirIrene González-Navarro, Víctor Urrea, Cristina Gálvez, et al.
Pageof 60

Showing results (461-470 of 600) with videos related to

Sort By:
Pageof 60
JCI Insight|February 19, 2026
Pediatric long COVID is characterized by myeloid CCR6 suppression and immune dysregulationJon Izquierdo-Pujol, Núria Pedreño-Lopez, Tetyana Pidkova, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 ProtocolJuliana Salazar, María J Arranz, Javier Martin-Broto, et al.
Vaccines|December 11, 2019
Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMixWesley de Jong, Lorna Leal, Jozefien Buyze, et al.
The Journal of Infectious Diseases|May 8, 2021
Early Initiation of Antiretroviral Therapy Following In Utero HIV Infection Is Associated With Low Viral Reservoirs but Other Factors Determine Viral ReboundJane R Millar, Nomonde Bengu, Vinicius A Vieira, et al.
Plos One|August 2, 2017
UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-conceptJavier Martinez-Useros, Tihomir Georgiev-Hristov, María Jesús Fernández-Aceñero, et al.
Current Medicinal Chemistry|April 11, 2025
Assessment of the Toxicity of Free and PLGA-Encapsulated Phospholipase A2 CB: An In Vitro ApproachVanessa Barbosa Pinheiro Gonçalves, Gabriel Acácio de Moura, João Pedro Viana Rodrigues, et al.
The American Journal of Tropical Medicine and Hygiene|July 8, 2015
Safety and Immunogenicity of a Dengue Virus Serotype-1 Purified-Inactivated Vaccine: Results of a Phase 1 Clinical TrialLuis Javier Martinez, Leyi Lin, Jason M Blaylock, et al.
BMC Cancer|December 18, 2014
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancerJavier Martinez-Useros, Maria Rodriguez-Remirez, Aurea Borrero-Palacios, et al.
Annals of Surgical Oncology|January 23, 2015
Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS)Jordi Rubió-Casadevall, Javier Martinez-Trufero, Xabier Garcia-Albeniz, et al.
The Journal of Clinical Investigation|November 29, 2024
Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoirIrene González-Navarro, Víctor Urrea, Cristina Gálvez, et al.
Pageof 60